-
Mashup Score: 16
Optimal first-line therapy for unresectable melanoma in-transit metastases has not been established, and options include isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesio…
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16
Optimal first-line therapy for unresectable melanoma in-transit metastases has not been established, and options include isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesio…
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
ESO future free educational opportunities. Application Open. Masterclass in clinical oncology, courses, postgraduate programme, certificates, refresher courses.
Source: www.eso.netCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 38Best Surgeons & Hospitals For Oncology Research - 8 month(s) ago
Find the best surgeons and hospitals, based on their hospital surgeries and published Oncology research. Featuring the All-Stars in Oncology.
Source: avantgardehealth.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12024 FHSAA 2A Boys Soccer Championship Orangewood Christian vs Carrollwood - 02/23/2024 | Live & On Demand - 9 month(s) ago
Watch high school sports and events nationwide, live and on demand, via the NFHS Network. Stream regular season and playoffs online from anywhere.
Source: www.nfhsnetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma - 1 year(s) ago
The Food and Drug Administration announced yesterday the approval of HEPZATO Kit to treat ocular melanoma that has spread to the liver. HEPZATO uses a hepatic d
Source: www.newswise.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma - 1 year(s) ago
The Food and Drug Administration announced yesterday the approval of HEPZATO Kit to treat ocular melanoma that has spread to the liver. HEPZATO uses a hepatic d
Source: www.newswise.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Julia Zager - 2 year(s) ago
A fundraising page for Julia Zager
Source: CMN HospitalsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Submit Late-Breaking Abstract — Cancer Metastasis - 2 year(s) ago
Abstract Submission for Oral & Poster Presentation The Organizing Committee encourages all cancer metastasis researchers to submit an abstract for presentation as poster or oral presentation. Your abstract should describe your most current, unpublished research which has not been presented at another meeting or conference. Trainees and Young Investigators should also apply for Travel Awards…
Source: Cancer MetastasisCategories: Hem/Oncs, Latest HeadlinesTweet
Congrats @MichelleDuganMD and Danielle DePalo MD from @MoffittNews, leading this multi-national, multi-institutional Herculean effort on the article comparing IO, ILI and TVEC as 1st line for patients with melanoma in‐transit metastases. https://t.co/DpGLENLoIB